T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$224B
| $6.72B | 0.62% |
13,316,751
+2,133,690
| +19% | +$1.01B |
|
27
Ross Stores
ROST
$80.8B
| $6.51B | 0.6% |
52,499,215
+4,567,503
| +10% | +$570M |
|
28
Eli Lilly
LLY
$1.08T
| $6.14B | 0.57% |
26,739,216
+584,215
| +2% | +$117M |
|
29
Wells Fargo
WFC
$264B
| $6.13B | 0.57% |
135,414,977
+6,424,515
| +5% | +$287M |
|
|
SCHW
30
Charles Schwab
SCHW
$186B
| $6.04B | 0.56% |
83,022,035
+2,285,311
| +3% | +$162M |
|
31
Roper Technologies
ROP
$39.5B
| $5.92B | 0.55% |
12,586,897
-263,634
| -2% | -$117M |
|
32
Cigna
CI
$72.4B
| $5.72B | 0.53% |
24,108,889
-4,058,870
| -14% | -$1.01B |
|
|
FISV
33
Fiserv Inc
FISV
$28B
| $5.41B | 0.5% |
50,623,252
-7,859,419
| -13% | -$914M |
|
34
Morgan Stanley
MS
$338B
| $5.35B | 0.5% |
58,330,109
-10,608,054
| -15% | -$910M |
|
35
NVIDIA
NVDA
$5.27T
| $5.34B | 0.5% |
266,962,880
-18,718,880
| -7% | -$300M |
|
|
MRSH
36
Marsh
MRSH
$91.3B
| $4.86B | 0.45% |
34,524,976
+468,887
| +1% | +$62.9M |
|
37
Match Group
MTCH
$8.45B
| $4.73B | 0.44% |
29,363,946
-1,312,754
| -4% | -$192M |
|
38
Elevance Health
ELV
$84.7B
| $4.66B | 0.43% |
12,200,199
-486,365
| -4% | -$186M |
|
39
HCA Healthcare
HCA
$89.1B
| $4.54B | 0.42% |
21,952,602
-1,521,734
| -6% | -$310M |
|
40
Goldman Sachs
GS
$301B
| $4.31B | 0.4% |
11,356,536
-1,993,223
| -15% | -$713M |
|
41
Humana
HUM
$44.8B
| $4.19B | 0.39% |
9,453,089
-636,051
| -6% | -$278M |
|
42
Shopify
SHOP
$196B
| $4.17B | 0.39% |
28,510,690
+790,310
| +3% | +$97.4M |
|
43
AstraZeneca
AZN
$246B
| $4.07B | 0.38% |
33,976,202
+4,952,637
| +17% | +$543M |
|
44
Atlassian
TEAM
$39.1B
| $4.04B | 0.37% |
15,713,335
+2,333,744
| +17% | +$546M |
|
45
Advanced Micro Devices
AMD
$774B
| $4.01B | 0.37% |
42,699,742
-287,292
| -0.7% | -$23.2M |
|
46
Applied Materials
AMAT
$417B
| $4B | 0.37% |
28,102,544
-4,602,691
| -14% | -$618M |
|
47
Booking.com
BKNG
$160B
| $3.94B | 0.36% |
44,963,175
-663,525
| -1% | -$61.9M |
|
48
Linde
LIN
$226B
| $3.76B | 0.35% |
13,005,666
-709,428
| -5% | -$207M |
|
49
Chipotle Mexican Grill
CMG
$40.5B
| $3.67B | 0.34% |
118,491,650
+3,768,250
| +3% | +$108M |
|
|
50
Pinterest
PINS
$13.4B
| $3.67B | 0.34% |
46,509,174
+27,066,282
| +139% | +$1.89B |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.